Imprimis Announces Multi-Center Clinical Trial for Dropless® TriMoxi™ (Triamcinolone Acetonide-Moxifloxacin for injection) Formulation in Canada
IMPRIMIS PHARMACEUTICALS (IMMY)
Last imprimis pharmaceuticals earnings: 5/10 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
imprimisrx.com
Company Research
Source: PR Newswire
SAN DIEGO, Aug. 1, 2018 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) through its ImprimisRx ophthalmology business today announced its Canadian partner, Advanced Dosage Forms Inc., will begin enrolling patients at McGill University Health Centre (MUHC) for a clinical trial of Imprimis's leading Dropless® (Triamcinolone Acetonide-Moxifloxacin) formulation after a No Objection Letter was issued by Health Canada on January 4, 2018 and analytical tests required by Health Canada were completed July 11, 2018. Additional patients will begin enrollment for the trial at Hôpital Maisonneuve-Rosemont on August 22, 2018. The prospective, randomized, controlled cross-over study of 200 bilateral cataract surgery patients will measure the outcomes of TriMoxi™ in one surgical eye versus traditional eye drop therapy in the same patient for the other surgical eye. The study may further efforts for public insurance payment for the formulation in Canada and in other markets.
Show less
Read more
Impact Snapshot
Event Time:
IMMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMMY alerts
High impacting IMPRIMIS PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics